Publication | Closed Access

MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease

Primary ImmunodeficiencyPotential Cell TherapyHuman RetrovirusImmunologyAntiviral ResponseAutoimmunityEpstein-barr Virus InfectionMagnesium DefectCell BiologyChronic Viral InfectionHivImmunotherapyMedicineCell TransplantationAdult T-cell Leukemia-lymphoma